IREB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.749900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.574400E-01
Normal-vs-Stage2
6.011800E-02
Normal-vs-Stage3
1.498800E-01
Normal-vs-Stage4
4.466600E-01
Stage1-vs-Stage2
4.990800E-01
Stage1-vs-Stage3
2.999600E-02
Stage1-vs-Stage4
9.588200E-01
Stage2-vs-Stage3
1.408640E-01
Stage2-vs-Stage4
5.411400E-01
Stage3-vs-Stage4
1.383410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.462500E-02
Normal-vs-AfricanAmerican
4.176400E-01
Normal-vs-Asian
5.545500E-02
Caucasian-vs-AfricanAmerican
2.824000E-01
Caucasian-vs-Asian
2.970400E-01
AfricanAmerican-vs-Asian
1.646020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.958400E-02
Normal-vs-Female
9.360000E-02
Male-vs-Female
2.237800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.410000E-01
Normal-vs-Age(41-60Yrs)
1.607020E-01
Normal-vs-Age(61-80Yrs)
3.030300E-02
Normal-vs-Age(81-100Yrs)
2.210500E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.937200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.179000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.116010E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.114390E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.357800E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.379400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.059520E-02
Normal-vs-Daily Drinker
5.243200E-03
Normal-vs-Weekly Drinker
5.219700E-02
Normal-vs-Occasional Drinker
1.204850E-01
Normal-vs-Social Drinker
1.805040E-01
Non Drinker-vs-Daily Drinker
4.643200E-01
Non Drinker-vs-Weekly Drinker
9.543400E-01
Non Drinker-vs-Occasional Drinker
2.458600E-01
Non Drinker-vs-Social Drinker
2.290400E-01
Daily Drinker-vs-Weekly Drinker
5.390600E-01
Daily Drinker-vs-Occasional Drinker
9.865900E-02
Daily Drinker-vs-Social Drinker
1.018770E-01
Weekly Drinker-vs-Occasional Drinker
4.100800E-01
Weekly Drinker-vs-Social Drinker
3.915800E-01
Occasional Drinker-vs-Social Drinker
9.057400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.029200E-01
Normal-vs-Grade 2
3.461200E-01
Normal-vs-Grade 3
6.911600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.869000E-01
Grade 1-vs-Grade 3
3.971600E-01
Grade 1-vs-Grade 4
5.029200E-01
Grade 2-vs-Grade 3
3.930800E-01
Grade 2-vs-Grade 4
3.461200E-01
Grade 3-vs-Grade 4
6.911600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.723800E-03
Normal-vs-NonDiabetic
2.332100E-02
Diabetic-vs-NonDiabetic
2.978400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.035000E-01
Normal-vs-NoPancreatitis
2.503800E-02
Pancreatitis-vs-NoPancreatitis
2.507200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.791600E-02
Normal-vs-N1
6.505800E-02
N0-vs-N1
3.260400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.514440E-01
Normal-vs-TP53-NonMutant
1.764170E-01
TP53-Mutant-vs-TP53-NonMutant
8.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
